Company Raptor Pharmaceutical Corp
Equities
US75382F1066
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
Kim Lee
IRC | Investor Relations Contact | - | 14-10-22 |
Corporate Officer/Principal | 62 | - | |
David Happel
PRN | Corporate Officer/Principal | 62 | 14-10-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 14-12-31 |
Timothy Walbert
BRD | Director/Board Member | 57 | 11-04-10 |
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 85,306,787 | 79,995,700 ( 93.77 %) | 0 | 93.77 % |
Company contact information
Horizon Pharmaceutical LLC
7 Hamilton Landing Suite 100
94949, Novato
+
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- Stock
- Company Raptor Pharmaceutical Corp